![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/03/01/2394022/10047/en/Acura-Pharmaceuticals-and-AD-Pharma-Amend-License-to-LIMITx-LTX-03.html
https://www.globenewswire.com/news-release/2022/02/14/2384235/10047/en/Acura-Pharmaceuticals-Provides-Development-Update-on-LTX-03.html
https://www.globenewswire.com/news-release/2021/08/16/2281550/10047/en/Acura-Pharmaceuticals-Announces-Second-Quarter-2021-Financial-Results.html
https://www.globenewswire.com/news-release/2021/07/26/2268955/10047/en/Acura-Pharmaceuticals-and-AD-Pharma-Amend-License-to-LIMITx-LTX-03.html
https://www.globenewswire.com/news-release/2021/06/07/2242538/10047/en/Acura-Pharmaceuticals-Provides-Development-Update-on-LTX-03.html
https://www.globenewswire.com/news-release/2020/10/28/2116311/0/en/Acura-Pharmaceuticals-and-AD-Pharma-Amend-License-to-LIMITx-LTX-03.html
https://www.globenewswire.com/news-release/2020/03/23/2005065/0/en/Acura-Pharmaceuticals-Provides-an-Update-on-the-Development-of-LTX-03.html
https://www.globenewswire.com/news-release/2020/01/02/1965839/0/en/Acura-Pharmaceuticals-Provides-an-Update-on-the-Development-of-LTX-03.html
https://www.contractpharma.com/contents/view_breaking-news/2019-09-16/catalent-acura-enter-clinical-manufacturing-pact/
http://www.in-pharmatechnologist.com/Ingredients/Bayer-ends-methamphetamine-abuse-deterrent-partnership-with-Acura